Indications
Treatment of symptomatic anaemia associated with chronic renal failure in adult patients and treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy
Composition
- Active substance
- epoetin theta
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ratioepo
- Active substance
- epoetin theta
- ATC code
- B03XA01
- Therapeutic area
- Anemia, Kidney Failure, Cancer
- Marketing authorisation holder
- Ratiopharm GmbH
- Status
- Application withdrawn